A study to assess nicotine levels in HTPs and cigarettes

  • Research type

    Research Study

  • Full title

    A Single-centre, Open-label, Randomised, Crossover Study to Assess the Nicotine Pharmacokinetics Following Use of Heated Tobacco Products and Combustible Cigarettes

  • IRAS ID

    339200

  • Contact name

    Donald Nortey

  • Contact email

    donald.nortey@simbecorion.com

  • Sponsor organisation

    JT International SA

  • Duration of Study in the UK

    0 years, 2 months, 3 days

  • Research summary

    The purpose of this study is to evaluate the levels of nicotine in the blood following use of three different tobacco products; Ploom X Advanced heated tobacco device and associated tobacco sticks (two different flavours) and a conventional combustible cigarette (own brand).

    The main objectives of this study are as follows:

    - To measure the levels of nicotine in the blood following single use of the three products.

    - To assess different subjective measures i.e., completion of specific questionnaires around product usage such as intent to use, urge to smoke and product satisfaction after a single use and a 4-hour ad libitum use session.

    - To assess overall product consumption i.e., number of cigarettes smoked/tobacco sticks used over a 4-hour ad libitum use session.

    - To provide general safety information for each of the three products.

    The study will enrol up to 24 participants (who are regular users of combustible cigarettes) and the study will comprise three product use periods; each period evaluating one of the products described across three study days.

    During each product use period, participants will be asked to complete two use sessions per day, one session where participants will use the product they have been assigned to on that day for a period of 4.5 minutes (10 puffs at 30 second intervals) and a second use session where participants will be required to use the product as they feel necessary for a period of up to 4 hours. During the single use session on each day, blood samples will be taken to measure the levels of nicotine in the blood. In addition, participants will be asked to complete a series of questionnaires in order to assess different measures such as product satisfaction, urge to smoke and the intent to use the products again.

  • REC name

    Wales REC 2

  • REC reference

    24/WA/0035

  • Date of REC Opinion

    26 Feb 2024

  • REC opinion

    Favourable Opinion